| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/13/2008 | US7371921 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 05/13/2008 | US7371852 Alkyl-linked nucleotide compositions |
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371836 PRO526 nucleic acids |
| 05/13/2008 | US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 05/13/2008 | US7371833 Nucleic acid molecules with specific recognition of native PrPSc, production and use |
| 05/13/2008 | US7371829 Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites |
| 05/13/2008 | US7371827 Antibodies against the PRO1126 polypeptide |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371824 PRO6093 polypeptides |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371818 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents |
| 05/13/2008 | US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 05/13/2008 | US7371755 Antiviral agents |
| 05/13/2008 | US7371745 Bis-transition-metal-chelate probes |
| 05/13/2008 | US7371742 Destroying tumor, viruses, bacteria cells ; retinoblastmas therapy |
| 05/13/2008 | US7371736 detecting tumors via microarray analysisof transfection pattern of cancer marker gene; antitumor agents; anticancer agents |
| 05/13/2008 | US7371726 Neutralizing GDF8 epitope-based growth enhancing vaccine |
| 05/13/2008 | US7371585 Membranes incorporating recognition moieties |
| 05/13/2008 | US7371584 Chromatographic medium contacted with test solution having activated magnetic particle antibodies which bind to cells |
| 05/13/2008 | US7371583 Using single test immunochromatographic strips to detect preferential components of hemoglobin; self-diagnostics; soil evaluation |
| 05/13/2008 | US7371582 Using flow through chromatography to detect preferential particles in solution |
| 05/13/2008 | US7371581 Process for the monitoring of contaminant removal during the purification process of a pharmaceutical product produced by a host cell |
| 05/13/2008 | US7371580 Reduced levels of background signal and enhanced specificity/ sensitivity; kits |
| 05/13/2008 | US7371579 Nickel-based reagents for detecting DNA and DNA-protein contacts |
| 05/13/2008 | US7371575 Process for ex vivo formation of mammalian bone and uses thereof |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371565 Apparatus and method for measuring intracellular reactions |
| 05/13/2008 | US7371564 Apparatus for automatically analyzing genetic and protein materials using photodiodes |
| 05/13/2008 | US7371563 Peelable and resealable devices for biochemical assays |
| 05/13/2008 | US7371562 Guided mode resonant filter biosensor using a linear grating surface structure |
| 05/13/2008 | US7371553 Chemically modified enzymes with multiple charged variants |
| 05/13/2008 | US7371541 Screening for substances capable of regulating signal transduction from dopamine or adenosine receptor to adenylate cyclase; measuring effector activity or index value; Gm1 |
| 05/13/2008 | US7371539 Targeted polypeptide degradation |
| 05/13/2008 | US7371538 Monolithic biosensors containing a modified bioluminescent microorganism; Optical Application Specific Integrated Circuit |
| 05/13/2008 | US7371537 Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use |
| 05/13/2008 | US7371536 Methods for transporting vitamin C |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371534 Reagent comprising dye, monoclonal antibody conjugated to quencher, and enzyme inhibitor; luminescent signal; sensitive, no washing |
| 05/13/2008 | US7371529 Methods and compositions for modulating gluconeogenesis using PGC-1 |
| 05/13/2008 | US7371526 Reacting nucleic acids with magnesium/sodium bisulfite in presence of polyamine catalyst (guanidine) to create point mutations; kits |
| 05/13/2008 | US7371524 Substituted azaporphyrins as fluorescence labels |
| 05/13/2008 | US7371520 Methods and apparati using single polymer analysis |
| 05/13/2008 | US7371517 High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
| 05/13/2008 | US7371515 Detection of cancer genes in sample; obtain cells, transform with vector, detect cell in which tumor development has been induced, detect gene associated with cancer |
| 05/13/2008 | US7371394 Antigenic composition of a Pseudomonas aeruginosa protein |
| 05/13/2008 | US7371386 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | US7371375 Protein |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | US7371314 Equilibrating biosensor for amperometric determination of creatinine in biological liquids |
| 05/13/2008 | US7371247 Method and apparatus for penetrating tissue |
| 05/13/2008 | US7370574 Device for determining and maintaining mold gyration angle in a gyratory compactor |
| 05/13/2008 | US7370544 Device for performing measurements and/or taking samples in molten metals |
| 05/13/2008 | US7370514 Determining quality of lubricating oils in use |
| 05/13/2008 | US7370513 System and method for monitoring features of a blast |
| 05/13/2008 | US7370511 Gas sensor with attenuated drift characteristic |
| 05/13/2008 | CA2485808C Oil/gas separation membrane for a gas sensor and method of making the same |
| 05/13/2008 | CA2483351C Systems and methods for predicting the bending stiffness of wood products |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2370535C Replica amplification of nucleic acid arrays |
| 05/13/2008 | CA2336261C Cyclin e2 genes and proteins |
| 05/13/2008 | CA2315239C Nucleotide and protein sequence of mammastatin and methods of use |
| 05/13/2008 | CA2299629C Method and apparatus for separating particulate matter from a liquid specimen |
| 05/13/2008 | CA2226729C Detection and biodegradation of explosives |
| 05/13/2008 | CA2212058C Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease |
| 05/13/2008 | CA2184916C Use of fibroblast growth factors to stimulate bone growth |
| 05/13/2008 | CA2166291C Htlv-iinra compositions and assays for detecting htlv infection |
| 05/08/2008 | WO2008055257A2 Cartridge for conducting diagnostic assays |
| 05/08/2008 | WO2008055242A2 Early detection of diabetes |
| 05/08/2008 | WO2008055199A1 Analyte monitoring |
| 05/08/2008 | WO2008055167A2 System and method for calibrating a determination of partial pressure of one or more gaseous analytes |
| 05/08/2008 | WO2008055112A2 Methods of treating autism and autism spectrum disorders |
| 05/08/2008 | WO2008055080A2 Method for blocking non-specific protein binding on a functionalized surface |
| 05/08/2008 | WO2008054947A2 Structure of acid beta-glucosidase and methods for identifying therapeutic agents |
| 05/08/2008 | WO2008054827A2 Bruton's tyrosine kinase activity probe and method of using |
| 05/08/2008 | WO2008054822A2 Compositions comprising alternatively spliced tissue factor (as tf) and methods for use |
| 05/08/2008 | WO2008054820A2 Thermoelectric sensor for analytes in a fluid and related method |
| 05/08/2008 | WO2008054764A2 Biomarkers for colorectal cancer |
| 05/08/2008 | WO2008054763A2 Biomarkers for breast cancer |
| 05/08/2008 | WO2008054724A2 Monoclonal antibodies against osteopontin |
| 05/08/2008 | WO2008054716A2 Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata |
| 05/08/2008 | WO2008054608A1 Analyte sensors and methods |
| 05/08/2008 | WO2008054597A2 Tyrosine phosphorylation sites |
| 05/08/2008 | WO2008054556A2 Methods and compositions for detection of a target nucleic acid sequence |
| 05/08/2008 | WO2008054534A2 Screening systems utilizing rtp801 |
| 05/08/2008 | WO2008054514A2 Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
| 05/08/2008 | WO2008054502A2 Diagnostic and therapeutic methods related to anthrax exposure |
| 05/08/2008 | WO2008054480A2 Enhanced biohazard detection system |
| 05/08/2008 | WO2008054394A2 Method and apparatus for detection of toxic agents using photosynthetic organisms |
| 05/08/2008 | WO2008054344A2 Detection of hidden explosives by spectroscopic terahertz imaging in reflection mode by means of a detector array and a frequency tunable free electron laser (fel) comprising an energy recovery linac (erl) |
| 05/08/2008 | WO2008054297A1 A method for determining brightness of paper pulp |
| 05/08/2008 | WO2008054282A1 Sensor unit for a surface plasmon resonance (spr) unit |
| 05/08/2008 | WO2008054030A1 IgG-BINDING PEPTIDE |
| 05/08/2008 | WO2008053992A1 Efficient method for detecting antigen, virus, cell and microorganism |
| 05/08/2008 | WO2008053973A1 Method of immunoassay of component to be measured |
| 05/08/2008 | WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell |
| 05/08/2008 | WO2008053901A1 METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN |
| 05/08/2008 | WO2008053900A1 Highly sensitive immunological analysis method and immunological analysis reagent for hepatitis b virus |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |